These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723 [TBL] [Abstract][Full Text] [Related]
5. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease. Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088 [TBL] [Abstract][Full Text] [Related]
6. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease? Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876 [TBL] [Abstract][Full Text] [Related]
7. Persistent trophoblast disease following partial molar pregnancy. Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033 [TBL] [Abstract][Full Text] [Related]
8. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen. Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153 [TBL] [Abstract][Full Text] [Related]
9. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole. Matsui H; Iitsuka Y; Suzuka K; Seki K; Sekiya S Hum Reprod; 2001 Jun; 16(6):1274-7. PubMed ID: 11387305 [TBL] [Abstract][Full Text] [Related]
10. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level. Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease. Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671 [TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France. Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886 [TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. Zalel Y; Dgani R Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):67-71. PubMed ID: 9031962 [TBL] [Abstract][Full Text] [Related]
14. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation. Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828 [TBL] [Abstract][Full Text] [Related]
15. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease. Miyoshi J; Ohba T; Fukunaga M; Katabuchi H Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448 [TBL] [Abstract][Full Text] [Related]
16. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report. Vejerslev LO; Larsen G; Jacobsen M Eur J Obstet Gynecol Reprod Biol; 1991 Jun; 40(1):73-7. PubMed ID: 1649776 [TBL] [Abstract][Full Text] [Related]
17. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation. Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641 [TBL] [Abstract][Full Text] [Related]
18. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands. Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825 [TBL] [Abstract][Full Text] [Related]
19. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review. Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183 [TBL] [Abstract][Full Text] [Related]
20. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis. Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]